Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Anxiety, Arthralgia, Asthenia, Autoimmune disorder, Chronic fatigue syndrome
Clinical narrative: chronic regional pain syndrome (CRPS); infections; frequent viruses and infections; autoimmune disease; small fiber neuropathy (SFN); postural orthostatic tachycardia syndrome; chronic fatigue syndrome (CFS); Information has been received from a lawyer referring to an adolescent female patient of unknown age regarding a case in litigation. Information about concurrent condition, history condition and concomitant medication was not reported. On 17-FEB-2017, at 13 years old, the patient received her first dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) (strength, dose, route, lot#, and expiration date were not reported). On 07-DEC-2017, the patient received her second dose of Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL). The patient's mother agreed to her receiving the vaccine injections after having been convinced that the vaccine was very safe, that the vaccine prevented cervical cancer, and that teenagers must get the vaccine. The patient and her mother relied upon the company's ubiquitous representations concerning the safety and efficacy of the vaccine, in consenting to her vaccination. Prior to receiving her injections, the patient was a highly energetic, extremely active, and a very out-going teenager. She volunteered her time with disabled children, played softball, and attended gymnastics. She was a cheerleader and had been accepted to the Varsity Cheerleading team at her school while she was only in the eighth grade. On 17-FEB-2017, during a visit to her pediatrician, her doctor recommended that she receive the vaccine, and stated the vaccine would help prevent her from getting human papillomavirus (HPV) and cervical cancer. Considering the doctor's recommendation, as well as the company's representations about the safety and efficacy of the vaccine, the patient's mother consented to her being injected with Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL), the "cervical cancer vaccine." The patient returned to her pediatrician's office on 07-DEC-2017 and received her second dosage of the vaccine. After her second vaccination, the patient began to experience severe fatigue. She spent that Christmas, her Christmas break, and New Year's Eve on the couch or in bed. She barely had the strength to get dressed and walk around. She also began to experience joint and muscle pain. A few weeks later, the patient was hospitalized with extremely severe vaginal pain and swelling. She was treated and release from the hospital, but she was still in pain. Her condition worsened a day later, and the patient was re-admitted and stayed in the hospital for several days. During the following weeks and months, the patient was in and out of multiple hospitals, suffering from pain and a variety of different viruses and infections. She was hospitalized for the first three weeks of her freshman year of high school, and thereafter had to continue with homeschool and tutoring from home. As the months progressed, so did the patient's injuries. She was seen by multiple physicians and specialists for various complaints and symptoms including but not limited to: weakness, extreme fatigue, headaches, rapid heartbeat, nausea, brain fog, intense joint and muscle pain, severe gastric/abdominal issues, frequent viruses and infections, depression, and anxiety. As a result of her post-vaccine symptoms, the patient was unable to experience the joys that come along with being a teenager. She had to drop out of gymnastics and cheerleading. She had missed a significant amount of high school classes due to her injuries. She was no longer the healthy, happy, and energetic person she once was. Based upon her chronic and severe post-vaccine symptoms and adverse events as outlined above, the patient had been diagnosed with various medical conditions, including but not limited to, postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndrome (CFS), chronic regional pain syndrome (CRPS), and small fiber neuropathy (SFN). The patient was also battling severe gastric/abdominal issues and headaches. As a proximate result of the company's wrongful acts and omissions and its negligent and fraudulent testing, labeling, manufacturing, marketing and promotion of the vaccine, the patient had suffered and continued to suffer severe and permanent physical injuries, and associated symptomology and had suffered severe and permanent emotional injuries, including pain and suffering. The patient also had a substantial fear of suffering additional and ongoing harms, including but not limited to now being at an increased risk of cancer, and future symptoms and harms associated with her autoimmune disease and other injuries caused by Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL). As a direct and proximate result of her vaccine-induced injuries, the patient had suffered and continued to suffer economic losses, including considerable financial expenses for medical care and treatment, and diminished income capacity, and she would continue to incur these losses and expenses in the future. The outcome of the events was not recovered. The causality between the events and Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recomb. Vaccine (GARDASIL) was considered to be related.  The lawyer considered the events to be disability.  Upon internal review, autoimmune disease was determined to be medically significant.